Sawaf Aziz 4
4 · Theravance Biopharma, Inc. · Filed May 22, 2024
Insider Transaction Report
Form 4
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Ordinary Shares
2024-05-20$9.10/sh−8,635$78,579→ 330,001 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.